CLPT vs DXCM · rev $23.0M vs P/E 63, rev $2.50B
Clearpoint Neuro Inc (CLPT) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported CLPT revenue for 2026-06-30 was $23.0M. Net income was -$20.9M. Revenue was up 89.7% from 2026-03-31 to 2026-06-30. CLPT currently screens at market cap $371.0M.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
CLPT currently screens at market cap $371.0M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the CLPT and DXCM stock pages for the full models.
Not investment advice.